🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Platform Response and Content Elimination

According to TikTok, the platform has taken down violative content and banned associated keywords and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Trading Activities

Research also discovered groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with photos of weight loss, glowing reviews and step-by-step guides for preparing or administering at residence.

After minutes of joining one group, a seller posted contact information, where the majority of transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, health issues or past usage.

Item Information and Pricing

Within these groups, posts show black plastic parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how long a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram stated it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has already encountered patients injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to possibly serious medical dangers”.